Theodosia Maina-Nock,Berthold Artur Nock,Marion de Jong Hendriks
申请号:
US16658554
公开号:
US20200121813A1
申请日:
2019.10.21
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention relates to a compound that inhibits the activity of a degrading enzyme for use in combination with a therapeutic or diagnostic compound, preferably a moiety conjugated peptide, in the diagnosis and/or treatment of a disease, in particular cancer, to enhance targeting of the therapeutic or diagnostic compound to the disease site.